Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Which transplant diagnostics company soared 22% after revenue jumped 39% to USD 139.4 million?

CareDx sells blood tests that monitor transplant recipients for signs of organ rejection, using donor derived cell free DNA to detect injury early. Published coverage says about USD 15 million of Testing Services revenue came from tests run in earlier periods, compared with USD …

Vinay Lochav | 03 November 2026

Which workforce lodging operator jumped 18% after raising 2026 revenue guidance to USD 710 million to USD 720 million?

Civeo rents workforce accommodation rooms to resource projects, so revenue depends on billed rooms and daily rates. The new guidance lifts adjusted EBITDA to USD 89 million to USD 92 million from USD 85 million to USD 90 million, raises capital spending to USD …

Vinay Lochav | 03 November 2026

Which luxury fashion group jumped 16% after cutting net debt to USD 336 million from USD 1.6 billion?

The company now expects adjusted revenue of about USD 3.42 billion, Michael Kors revenue of about USD 2.77 billion and Jimmy Choo revenue of about USD 650 million. Third quarter guidance is for revenue of about USD 1.005 billion, which includes the USD 20 …

Vinay Lochav | 03 November 2026

Why did a communications platform that grew revenue 20% to USD 1.56 billion still guide fourth quarter organic growth to just 11 to 12%?

A high price to earnings multiple capitalizes expected growth, so a guide that points to slower growth can reduce the multiple even when the quarter is strong. Management said the smaller beat came mainly from a modest slowdown in messaging, the company's largest product, …

Vinay Lochav | 03 November 2026

Why did a photo enforcement and tolling firm with Government Solutions up 12% see Commercial Services revenue drop 14%?

Commercial Services depends on a small number of large rental car customers. A pre-earnings preview dated October 22, 2026 described how the renewed contract with Avis Budget Group carries lower pricing that flows through the segment starting in the third quarter. The renewal with …

Vinay Lochav | 03 November 2026

Why did a sickle cell drug that lifted hemoglobin response to 40.6% from 2.9% just get an FDA decision delay to February 1, 2027?

The REMS question traces to thalassemia. In those trials, 5 of 301 patients had liver injury, 2 of them serious. Mitapivat has been sold for thalassemia under theBrandAQVESME since late January, only under a REMS, according to published coverage. Agios reports no sickle cell …

Vinay Lochav | 03 November 2026

Which USD 6.5 billion a quarter medical device maker just cut its 2026 organic growth outlook from 8.3 to 9.3% to 6.5 to 7%?

The weak spot was joint replacement. Hip sales fell 1% while knee sales rose 1.1%, whereas Johnson & Johnson (NYSE:JNJ) reported knee growth of 2.5% and hip growth of 3.2% in the same period, according to published coverage. Lobo said it is now clear …

Vinay Lochav | 03 November 2026

Which Medicare Advantage insurer grew revenue 36.7% to USD 1.36 billion yet guided to a USD 28 million adjusted EBITDA loss for the fourth quarter?

The medical benefits ratio compares medical costs with premiums, so a 240 basis point rise means a larger share of each premium dollar went to care. The company cited Part D seasonality, the timing of clinical investments, elevated appeals and disputes, and higher costs …

Vinay Lochav | 03 November 2026

Why did a record 661 million users fail to stop a social platform's growth from slowing from 18% to 12%?

Management traced about 3 points of the slowdown from 18% to 12% to European changes in de minimis rules for low-value imports, which led cross-border sellers to cutAdvertisingby more than expected. The mechanism matters: advertisers bid in an auction, so when a group of …

Vinay Lochav | 03 November 2026

Which two staples stocks climbed up to 3.9% on a day the S&P 500 fell 1.8%?

Key HighlightsMondelez International (NASDAQ:MDLZ) reported third quarter netRevenueof USD 9.967 billion, up 2.3%, with organic growth of 2.1% andVolumeand mix adding 1.8 points, and reaffirmed organic growth of at least 2% for 2026.Colgate-Palmolive (NYSE:CL) reported net sales of USD 5.37 billion, up 4.6%, and …

Vinay Lochav | 03 November 2026
Support

Hi! How can we help you today?

Loading…